Upl Ltd v. The Controller Of Patents Designs And Trademark

197814319

Upl Ltd challenged the rejection of its patent application concerning a novel agrochemical fungicide combination. The core dispute centered on whether adding a multi-site fungicide to existing SDHI combinations provided a synergistic and unexpected technical advantage, or if it was merely an obvious aggregation of known substances. The Calcutta High Court found that the original order lacked proper analysis of the experimental data supporting synergy and noted procedural lapses by the Controller in failing to issue a Second Examination Report (SER). Consequently, the court set aside the rejection order and remanded the matter for fresh consideration.

Jurisdiction
India
Court
Calcutta High Court
Case Number
197814319
Judge(s)
Ravi Krishan Kapur

Detailed Summary

In the high-stakes world of agrochemical innovation, where a single combination can reshape crop protection, the difference between a granted patent and a rejected application often comes down to two things: the strength of your scientific evidence and the rigor of the examination process. For UPL Ltd, a major player in agricultural solutions, a promising invention sat in limbo because the patent office failed on both fronts. This case is a wake-up call for every founder and IP professional: even a genuinely novel invention can be killed by weak examination, and even a strong invention can be saved when the courts demand proper scrutiny.

UPL Ltd, a prominent agrochemical company, filed a patent application for a novel fungicide combination designed to tackle crop diseases more effectively. The invention centered on adding a multi-site fungicide to existing SDHI (Succinate Dehydrogenase Inhibitor) combinations, a class of fungicides widely used in modern agriculture. The company believed this combination produced a synergistic effect, meaning the combined ingredients worked better together than the sum of their individual parts. However, the Controller of Patents and Designs rejected the application, essentially concluding that the combination was an obvious aggregation of known substances rather than a true technical breakthrough. This rejection set the stage for a legal showdown at the Calcutta High Court.

UPL Ltd argued forcefully that its combination was not a mere mixing of known ingredients but a genuine invention with synergistic and unexpected technical advantages. The company pointed to experimental data demonstrating that the combination produced results greater than what each component could achieve alone. On the other side, the Controller maintained that the addition of a multi-site fungicide to existing SDHI combinations was a predictable step that any skilled person in the agrochemical field would naturally take. The Controller's position essentially boiled down to: this isn't inventive, it's just common sense in the industry. The legal friction centered on a critical question: does the experimental data truly demonstrate synergy, or is it just a numerical coincidence that doesn't rise to the level of patentable innovation?

The Calcutta High Court sided with UPL Ltd, but not entirely on the merits of the invention itself. Instead, the court identified two critical failures in the original rejection order. First, the court found that the Controller's order lacked proper analysis of the experimental data that UPL had submitted to support its synergy claims. The rejection appeared to dismiss the data without engaging with what it actually showed. Second, and perhaps more damning, the court noted a procedural lapse: the Controller had failed to issue a Second Examination Report (SER), a statutory requirement that gives applicants a fair chance to respond to objections before a final rejection. Because of these infirmities, the court set aside the rejection order and remanded the matter back for fresh consideration. The invention itself was neither definitively approved nor definitively denied; instead, it was given another chance to be properly examined.

For founders, startup leaders, and IP professionals, this case delivers two powerful lessons. First, when claiming synergistic effects in combination inventions, technical evidence is everything. Numerical results alone won't cut it; you need robust experimental data that clearly demonstrates why the combination produces unexpected advantages beyond what each component contributes individually. Second, and equally important, patent offices must follow statutory procedural mandates to the letter. The failure to issue a Second Examination Report was not a minor oversight; it was a fatal infirmity that invalidated the entire rejection. If you're filing patents involving combinations, invest in strong scientific documentation and ensure your IP counsel rigorously tracks every procedural step in the examination process. A great invention deserves a

Practitioner Note

This case demonstrates the evidentiary and procedural standards applied in patent matters before Calcutta High Court. Understanding the court's reasoning in Upl Ltd vs The Controller Of Patents Designs And Trademark is valuable context for structuring arguments or assessing risk in similar proceedings.

Related Cases

patent1907024

Novartis Ag.vsCipla Ltd.

Cipla Ltd. opposed Novartis AG's patent application for a new crystal form of imatinib mesylate. The IPAB found that the subject matter was merely a new form of a known substance without significant enhancement in efficacy, thus failing Section 3(d). Furthermore, the court disqualified the application due to improper claiming of Swiss priority.

patent162360059

Ms Industries And Spirits P LtdvsM/S. Allied Blenders And Distillers Pvt ...

This appeal challenged the grant of ex parte ad interim injunctions by the City Civil Court, Hyderabad. The original suit involved allegations of trademark and copyright infringement (passing off) concerning alcoholic beverages, specifically comparing 'Officer's Choice' with 'Manjeera Classic No.1 Whisky'. However, the Telangana High Court ultimately set aside these injunction orders, finding that the lower court failed to provide reasons for granting the ex parte relief as mandated by law.

patent81055087

Sanjeev KhandelwalvsGanesh Medicals

The plaintiff filed a suit alleging infringement of his patent (No. 197822) against three defendants. Subsequently, the parties executed a Deed of Compromise dated 22.11.2010. The court disposed of the suit based on this compromise.

patent135282360

Yang, LipingvsController Of Patents And Designs

Yang, Liping appealed an order dated November 18, 2013, which refused his Indian Patent Application (No. 2769/DELNEP/2004). The refusal was based on the patent not meeting Section 2(1)(j) of the Indian Patent Act, 1970. The court issued directions for service and filing of replies to proceed with the appeal.

patent191156248

Hatsun Agro Product Ltd.vsM/S.Himachal Milk Food Products

Hatsun Agro Product Ltd. filed a civil suit against M/S.Himachal Milk Food Products alleging infringement of its trademarks and copyrights, specifically concerning the use of similar containers and labels on dairy products like Ghee. The plaintiff sought permanent injunctions and damages for passing off. However, before the court could rule on the merits of the case, the plaintiff moved to withdraw the suit, which was subsequently granted by the Madras High Court.

Arctic Invent — IP Strategy

Dealing with a patent challenge?

Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.

Talk to our patent team →

Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.

Strategy Consult

Facing a similar patent matter?

Arctic's litigation team uses precedent data like this to build winning arguments.

Get a Strategy Call